IRX Therapeutics, Inc. v. Landry

2017 NY Slip Op 3702, 150 A.D.3d 446, 55 N.Y.S.3d 4
CourtAppellate Division of the Supreme Court of the State of New York
DecidedMay 9, 2017
Docket3943 652614/16
StatusPublished
Cited by10 cases

This text of 2017 NY Slip Op 3702 (IRX Therapeutics, Inc. v. Landry) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
IRX Therapeutics, Inc. v. Landry, 2017 NY Slip Op 3702, 150 A.D.3d 446, 55 N.Y.S.3d 4 (N.Y. Ct. App. 2017).

Opinion

Order, Supreme Court, New York County (Charles E. Ramos, J.), entered on or about December 15, 2016, which, in effect, granted the branch of defendant’s motion that sought dismissal of the action pursuant to CPLR 3211 (a) (4), unanimously affirmed, with costs.

Defendant, a Texas resident, did not establish that his telephone and email contacts with plaintiff’s chief executive officer in New York were, as a matter of law, insufficient to warrant exercise of personal jurisdiction over him pursuant to CPLR 302 (a) (1) (see Fischbarg v Doucet, 9 NY3d 375 [2007]; C. Mahendra [NY], LLC v National Gold & Diamond Ctr., Inc., 125 AD3d 454, 457 [1st Dept 2015]).

Nevertheless, the motion court providently exercised its discretion in dismissing this action based on the pendency of an action in federal court in Texas concerning the same alleged contract (see Whitney v Whitney, 57 NY2d 731, 732 [1982]; see also CPLR 3211 [a] [4]). In the Texas action, defendant and two other individuals not named as parties in this action allege that plaintiff breached a contract. The Texas action is thus more comprehensive than this declaratory judgment action and will address defendant’s claim that the parties never entered into an enforceable contract; moreover, dismissal of this action in favor of the Texas action will avoid duplicative, vexatious litigation (see White Light Prods. v On The Scene Prods., 231 AD2d 90 [1st Dept 1997]; Continental Ins. Co. v Polaris Indus. Partners, 199 AD2d 222, 223 [1st Dept 1993]). Further, the record shows that the dispute has a significant nexus with Texas since the three individuals seeking to enforce the alleged contract with plaintiff are Texas residents, all work contemplated under the alleged contract was to be done in Texas, and plaintiff reached out to defendant for the specific *447 purpose of expanding its business into Texas and making use of defendant’s connections there in an effort to raise capital.

Although this action was filed first, chronology is not dispositive, particularly since both actions are at the earliest stages of litigation (see San Ysidro Corp. v Robinow, 1 AD3d 185, 186 [1st Dept 2003]), and since the format of this action (i.e., a declaratory judgment action) suggests that it was responsive to defendant’s threat of litigation (see L-3 Communications Corp. v SafeNet, Inc., 45 AD3d 1, 9 [1st Dept 2007]). The record also suggests that plaintiff commenced this action preemptively in an effort to gain a tactical advantage and deprive defendant of his choice of forum (id.; Certain Underwriters at Lloyd’s, London v Hartford Acc. & Indem. Co., 16 AD3d 167 [1st Dept 2005]).

Concur—Acosta, J.P., Renwick, Mazzarelli, Gische and Gesmer, JJ.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Aerogen LLC v. Tapjets Holdings Inc.
2025 NY Slip Op 02990 (Appellate Division of the Supreme Court of New York, 2025)
Aerogen LLC v. Tapjets Holdings Inc.
2024 NY Slip Op 51341(U) (New York Supreme Court, New York County, 2024)
St. Paul Fire & Mar. Ins. Co. v. Getty Props. Corp.
2024 NY Slip Op 03508 (Appellate Division of the Supreme Court of New York, 2024)
RDF Agent, LLC v. Electric Red Ventures, LLC
2024 NY Slip Op 02384 (Appellate Division of the Supreme Court of New York, 2024)
E D & F Man Sugar Ltd. v. Gellert
2022 NY Slip Op 00813 (Appellate Division of the Supreme Court of New York, 2022)
Robert Owen Lehman Found., Inc. v. Wien
2021 NY Slip Op 04799 (Appellate Division of the Supreme Court of New York, 2021)
XL Specialty Ins. Co. v. Continental Cas. Co.
2020 NY Slip Op 2116 (Appellate Division of the Supreme Court of New York, 2020)
Matter of American Express Co. v. United States Virgin Is. Dept. of Justice
2019 NY Slip Op 8618 (Appellate Division of the Supreme Court of New York, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
2017 NY Slip Op 3702, 150 A.D.3d 446, 55 N.Y.S.3d 4, Counsel Stack Legal Research, https://law.counselstack.com/opinion/irx-therapeutics-inc-v-landry-nyappdiv-2017.